Medical Malpractice USA
The us Food and Drug Administration (fda) is "the single greatest obstacle to doing anything effective" about Vioxx, according to the agency's drug safety officer David Graham. He was speaking at an unprecedented roundtable of medical whistleblowers at Washington, usa. Merc and Co, the makers of Vioxx, shelved this drug in September 2005 after studies linked it to heart ailments. But this once-popular anti-arthritic drug has not been banned
Graham was among the five high-profile whistleblowers invited by journalist Jeanne Lenzer to share accounts of malpractices in medicine and medical research. "One of the lessons of the roundtable," says Lenzer, is that "ties between drug regulators and industry influences new drug approval". Graham's testimony supports her argument: "The fda gets money from drug companies to approve new drugs quickly." Kathleen Moschkau, a former drug representative, came up with another startling revelation. A movie, in fact: Side effects. A fictionalised account of her experiences, it shows how companies buy doctors's prescribing records so that drug representatives know what drugs doctors are prescribing and so tailor their marketing.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.